ArticleGene therapy2024

Targeting serum response factor (SRF) deactivates ΔFosB and mitigates Levodopa-induced dyskinesia in a mouse model of Parkinson's disease.

Piniel Alphayo Kambey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.